05/01/2026
🌍 What’s New(s) Monday | Global Cannabis Update
5 January 2026
As we step into 2026, one global cannabis conversation continues to gain momentum:
🧪 Cannabis rescheduling and expanded medical research are shaping the year ahead.
Recent regulatory shifts — particularly in major international markets — are formally recognising the medical value of cannabis and opening the door to:
• Expanded clinical research
• Stronger regulatory frameworks
• Greater emphasis on pharmaceutical standards
• Higher expectations around quality, consistency, and compliance
This signals a key moment in the industry’s evolution — where science, regulation, and process are increasingly defining credibility and long-term success.
💬 We’d love to hear your view:
Do you think regulatory reform will accelerate medical cannabis innovation in 2026 — or create new challenges for producers?
👇 Share your thoughts below.